European Patent Office

T 1741/22 (New medical data/ROCHE) of 26.07.2024

European Case Law Identifier
ECLI:EP:BA:2024:T174122.20240726
Date of decision
26 July 2024
Case number
T 1741/22
Petition for review of
-
Application number
16153964.8
IPC class
G06F 19/00
Language of proceedings
English
Distribution
Distributed to board chairmen and members (B)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
Abstract on EPC2000 Art 056
Application title
System and method for analyzing glucose monitoring data indicative of a glucose level, and a computer program product
Applicant name
Roche Diabetes Care GmbH
F. Hoffmann-La Roche AG
Opponent name
-
Board
3.5.05
Headnote
-
Relevant legal provisions
European Patent Convention Art 56European Patent Convention Art 84Guidelines_Part G, Chapter II, 3(3)Rules of procedure of the Boards of Appeal 2020 Art 020(1)Rules of procedure of the Boards of Appeal 2020 Art 020(2)
Keywords
Claims - clarity (no)
Inventive step - (no): no credible technical effect produced by deriving additional data from medical measurements
Catchword
The mere generation of further data from measurement data already collected from the human body is not a technical effect (T
2681/16 and the Guidelines for Examination not followed). See Reasons 2.3 of the decision.
Citing cases
-

Order

For these reasons it is decided that:

The appeal is dismissed.